<DOC>
	<DOCNO>NCT01797705</DOCNO>
	<brief_summary>The purpose protocol improve current FDA-approved continuous positive pressure auto-titration algorithm , include treatment precision , residual disease detection characteristic phenotyping DeVilbiss brand AutoAdjust CPAP device .</brief_summary>
	<brief_title>Revised Algorithm Next Generation DeVilbiss Healthcare AutoAdjust Continuous Positive Airway Pressure ( CPAP )</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Apnea hypopnea index ≥ 15 / hour sleep diagnostic polysomnogram , diagnostic component split night polysomnogram Sleep efficiency report CPAP titration night PSG &gt; 78 % Diagnosis moderate severe obstructive sleep apnea ( AHI ≥15 ) central/complex sleep apnea On stable CPAP APAP [ Automatic Positive Airway Pressure ] therapy , compliant use average 4 hour nightly Age 2175 year Predominately central sleep apnea 10 subject Willingness give write informed consent ability adhere visit schedule Diagnosis mild sleep apnea CPAP naïve patient Comorbid condition render participation risk . These may include patient congestive heart failure , COPD [ Chronic Obstructive Pulmonary Disease ] psychiatric illness Allergies mask material Evidence another primary sleep disorder Evidence arouse periodic limb movement titration Contraindications list product labeling Pregnant Currently diagnose depression symptomatic Deemed medically unsuitable investigator Evidence type infection treatment infectious condition period research participation Have bilevel requirement , prescribe bilevel therapy device CPAP pressure &gt; 15cmH2O Subjects tracheotomy Uncontrolled hypertension Require supplemental oxygen Stimulants , major tranquillizer antipsychotic Restless Leg Syndrome Periodic Leg Movement Index &gt; 5 per hour</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>